Love Lifesciences develops therapeutic-agnostic injection safety devices designed to enhance the patient injection experience and improve medication adherence. Their technology addresses the issue of medication non-adherence, which contributes to 10% of U.S. hospitalizations and costs the global pharmaceutical industry $630 billion annually.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Medication non-adherence is a significant issue, contributing to a substantial number of hospitalizations and resulting in considerable financial losses for the pharmaceutical industry. Traditional injection methods can be cumbersome, leading to patient discomfort and reduced adherence to prescribed medication regimens.
Solution
Love Lifesciences is developing UniPen, a therapeutic-agnostic injection safety device designed to improve the patient injection experience and enhance medication adherence. UniPen aims to streamline the process of injectable medication delivery, making it more efficient, safe, and precise for a wide range of therapies. The platform is designed to meet pharmaceutical industry quality and manufacturing standards, offering pharmacies a streamlined pathway to launching sterile injectable products in a patient-friendly device. By minimizing timelines and upfront costs, UniPen offers pharmacies enhanced patient satisfaction outcomes and financial benefits previously only available to pharmaceutical companies.
Target Audience
The primary target audience includes compounding pharmacies and pharmaceutical companies seeking to improve patient adherence to injectable medications and enhance the overall injection experience.
Features
- Therapeutic-agnostic design compatible with a diverse range of injectable medications
- Integrated safety features to prevent needlestick injuries and ensure proper medication delivery
- User-friendly design to improve the patient injection experience and promote medication adherence
- Streamlined pathway for pharmacies to launch sterile injectable products
- Platform meeting pharmaceutical industry quality and manufacturing standards